Context Prevalence of obesity and the metabolic syndrome is rapidly increasing in
developing countries, leading to increased morbidity and mortality due to type 2 diabetes …

Fatty liver disease that develops in the absence of alcohol abuse is recognized increasingly
as a major health burden. This report summarizes the presentations and discussions at a …

Definitions for overweight and obesity are universally applied using body mass index (BMI),
based on morbidity and mortality data derived from white populations. However, several …

There is worldwide epidemic of non-alcoholic fatty liver disease (NAFLD). NAFLD is a
clinical entity related to metabolic syndrome. Majority of the patients are obese but the …

A key challenge for improving the efficacy of passive drug delivery to tumor sites by a
nanocarrier is to limit reticuloendothelial system uptake and to maximize the enhanced …

Recent studies provide clues regarding the cellular mechanisms that determine whether
excess lipid accumulation is well tolerated or cytotoxic. Critical in this process are …

Obesity and dyslipidemia are emerging as major public health challenges in South Asian
countries. The prevalence of obesity is more in urban areas than rural, and women are more …

Background & Aims: Abdominal fat accumulation (visceral/hepatic) has been associated
with hepatic insulin resistance (IR) in obesity and type 2 diabetes (T2DM). We examined the …

Objective: The present study aims at determining the stability of a popular type 2 diabetes rat
model induced by a high-fat diet combined with a low-dose streptozotocin injection …

BACKGROUND The diagnosis of NAFLD and NASH remains one of clinicopathologic
correlation.[1][2][3] In evaluation of subjects suspected to have NAFLD or NASH, standard …